| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc. (MLYS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. MLYS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.90M | $211.27M | - | |
| Dir | 5.46M | $145.85M | - | |
| CEO | 689.3K | $18.43M | - | |
| Dir | 588.2K | $15.72M | - | |
| Other | 57.1K | $1.53M | -14,474 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Karydas Daphne | Director | Sale+OE | 3,000 | $25.00 | $75,000.00 | -32.6% | - | - | |
| Jun 17, 2026 | Rodman David Malcom56 | Chief Medical Officer | Sale+OE | 14,474 | $24.19 | $350,086.83 | -11.2% | - | - | |
| Apr 17, 2026 | Rodman David Malcom56 | Chief Medical Officer | Sale+OE | 416 | $31.33 | $13,033.28 | -0.6% | - | - | |
| Apr 15, 2026 | Rodman David Malcom56 | Chief Medical Officer | Sale+OE | 20,406 | $26.89 | $548,672.35 | -12.3% | - | - | |
| Apr 13, 2026 | Congleton Jon47 | Chief Executive Officer | Sell | 15,730 | $26.83 | $421,979.27 | -2.2% | - | - | |
| Apr 9, 2026 | Rodman David Malcom56 | Chief Medical Officer | Sale+OE | 2,170 | $27.38 | $59,414.60 | -2.8% | - | - | |
| Mar 13, 2026 | Rodman David Malcom56 | Chief Medical Officer | Sale+OE | 20,406 | $26.61 | $542,973.39 | -6.1% | -8.6% | - | |
| Jan 14, 2026 | Rodman David Malcom56 | Chief Medical Officer | Sale+OE | 19,076 | $32.66 | $623,114.66 | -14.5% | -20.3% | - | |
| Jan 12, 2026 | Congleton Jon47 | Chief Executive Officer | Sell | 16,236 | $32.62 | $529,639.60 | -1.2% | -19.3% | - | |
| Jan 12, 2026 | Levy Adam Scott | CFO And Secretary | Sell | 10,758 | $32.14 | $345,723.39 | -55.5% | -19.3% | - |